Dr. Boyd Haley
Chief Scientist and CEO of AmeraMed
Over the last two decades Dr. Boyd Haley, PhD. has lectured throughout the world and testified before Congressional oversight committees and the Institute of Medicine regarding various aspects of mercury toxicity and neurological diseases.
Emeramide is a lipophilic, di-thiol metal chelator, and antioxidant. Orphan Drug Designation was received for the treatment of mercury toxicity in the EU and US in 2012. Pre-clinical safety studies, a Phase I trial, and two Phase IIa trials have been performed. The Company is working to obtain marketing authorization in the EU and the US for the treatment of mercury toxicity in both humans and animals. A Phase IIb pivotal study began in October, 2018 in Colombia South America.
High oxidative stress is present in autistic children; thimerosal seems to be the culprit which is found in vaccines
Thimerosal free vaccines are available, but doctors choose to use the other because they are cheaper
Our government has never done a study comparing the health outcomes of vaccinated children vs unvaccinated children
Dr. Haley has a product that clearly removes mercury and heavy metals which the FDA will not approve in spite of positive safety studies
To get rid of viruses, the body must have high glutathione levels
Oxidative stress explained
Alzheimers gets started with an environmental toxin namely mercury, from fillings, and the environment
The longer you have mercury amalgam fillings in your mouth, the more likely you’ll get sick
Vitamin C is the best defense against oxidative stress
Boyd Haley PhD and his long journey researching Mercury an getting to market a natural way to detox it, April 21, 2020